Evidence map›Paper›PMID 31163649›Full record

ArticleInternational journal of molecular sciences2019

Insight of the Interaction between 2,4-thiazolidinedione and Human Serum Albumin: A Spectroscopic, Thermodynamic and Molecular Docking Study.

Safikur Rahman, Md Tabish Rehman, Gulam Rabbani, Parvez Khan, Mohamed F AlAjmi, Md Imtaiyaz Hassan, Ghazala Muteeb, Jihoe Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Kanamycin-Mediated Conformational Dynamics ofFrontiers in molecular biosciences · 2021
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Safikur RahmanDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Korea. shafique2@gmail.com.ORCID 0000-0002-6282-8706
Md Tabish RehmanDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. mrehman@ksu.edu.sa.ORCID 0000-0003-2341-900X
Gulam RabbaniNano Diagnostics; Devices (NDD), Room B-312 IT, Medical Fusion Center, Gumidae-ro, 350-27, Gumi-si, Gyeongbuk 39253, Korea. rbbgulam@gmail.com.
Parvez KhanCenter for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India. parvezynr@gmail.com.ORCID 0000-0002-8566-0248
Mohamed F AlAjmiDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. malajmii@ksu.edu.sa.
Md Imtaiyaz HassanCenter for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India. mihassan@jmi.ac.in.
Ghazala MuteebDepartment of Nursing, College of Applied Medical Sciences, King Faisal University, 31982 Al-Ahsa, Saudi Arabia. graza@kfu.edu.sa.ORCID 0000-0002-3328-3559
Jihoe KimDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Korea. kimjihoe@ynu.ac.kr.ORCID 0000-0002-1905-1452
Jamia Millia Islamia · INKing Saud University · SAYeungnam University · KRKing Faisal University · SA

Funding

Deanship of Scientific Research, King Faisal University Nasher track (186161)National Research Foundation of Korea NRF-2018R1C1B5046582
6 · The paper itself

Abstract

Thiazolidinedione derivatives (TZDs) have attracted attention because of their pharmacological effects. For example, certain TZDs have been reported to ameliorate type II diabetes by binding and activating PPARs (peroxisome proliferator-activated receptors). Nonetheless, no information is available on the interaction between the heterocyclic 2, 4-thiazolidinedione (2,4-TZD) moiety and serum albumin, which could affect the pharmacokinetics and pharmacodynamics of TZDs. In this study, we investigated the binding of 2,4-TZD to human serum albumin (HSA). Intrinsic fluorescence spectroscopy revealed a 1:1 binding stoichiometry between 2,4-TZD and HSA with a binding constant (

Indexed as

Molecular Docking SimulationSpectrum AnalysisThermodynamicsAlgorithmsBinding SitesCalorimetryFluorescence Resonance Energy TransferHumansHydrogen BondingMolecular Dynamics SimulationProtein BindingProtein UnfoldingSerum Albumin, HumanStructure-Activity RelationshipThiazolidinediones2,4-thiazolidinedioneSerum Albumin, HumanThiazolidinedionesantidiabetichuman serum albuminthermodynamic stabilityThiazolidinedione

Identifiers

PMID31163649
PMCPMC6600547
OpenAlexW2947338364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.